2023 Annual Meeting | C36 - New Treatments in Pediatric Epilepsy Syndromes

Date Sunday 04/23/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Korwyn Williams, MD, PhD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), Child Neurology and Developmental Neurology

Learning Objectives The age of precision medicine is upon us. For some of the more challenging pediatric epilepsy syndromes such as tuberous sclerosis, Lennox-Gastaut and Dravet, there are now medications that are specifically approved to treat the seizures associated with them. Participants should be able to recognize syndrome-specific treatments, as well as potential risks for some of the most refractory epilepsies in pediatric patients.

This program is supported in part by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM EST	Introduction	Overview Korwyn Williams, MD, PhD, FAAN
07:05 AM - 07:40 AM EST	Speaker	What’s New with Lennox-Gastaut Joyce Y. Wu, MD
07:40 AM - 08:15 AM EST	Speaker	The Changing Face of Tuberous Sclerosis Treatment Korwyn Williams, MD, PhD, FAAN
08:15 AM - 08:50 AM EST	Speaker	CDKL5: Small Numbers, but Mighty Treatments Randa G. Jarrar, MD
08:50 AM - 09:00 AM EST	Discussion	Questions and Answers Korwyn Williams, MD, PhD, FAAN, Randa G. Jarrar, MD, Joyce Y. Wu, MD

Faculty Disclosures
Joyce Y. Wu, MD	Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. The institution of Dr. Wu has received research support from National Institutes of Health. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health.
Randa G. Jarrar, MD	Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
Korwyn Williams, MD, PhD, FAAN	Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calcium and Company.

��ɫ��

��ɫ��